Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Recruitment Status: Completed"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Completed%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (1.693)
1
Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients : Combined MEK Inhibitor Trametinib and RTK Inhibitor Anlotinib Therapy in Non-G12C KRAS-Mutant Non-Small Cell Lung Cancer Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Natural Killer Cells and Bortezomib to Treat Cancer : Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity With Bortezomib
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT) : Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Effects of Comprehensive Postoperative Pulmonary Tele-Rehabilitation in Elderly Patients With Resectable Lung Cancer : Effects of Comprehensive Postoperative Pulmonary Tele-Rehabilitation in Elderly Patients With Resectable Lung Cancer: A Randomized Controlled Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) : Anti-PD-L1 Antibody MEDI4736 in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC). A Multicenter Single-arm Phase II Trial.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) : A Phase 1, Open-Label, Multicenter, Drug-Drug Interaction Study of TAK-788 and Midazolam, a Sensitive CYP3A Substrate, in Patients With Advanced Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors : A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants : A Two-part, Single Center, Open-label Study to Investigate the Pharmacokinetics, Metabolic Disposition, Mass Balance and Absolute Bioavailability of BAY 2927088 in Healthy Male Participants
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
TGRX-326 Phase I/II Pharmacokinetic Study : A Randomized, Open-label, Single-dose, 3-cycle, 6-sequence, Crossover Study Evaluating Food Effect on Pharmacokinetic Profiles of TGRX-326 in Chinese Healthy Subjects and Effect of Drug Specification on Bioavailability in Human
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799) : A Phase 2 Trial of Pembrolizumab (MK-3475) in Combination With Platinum Doublet Chemotherapy and Radiotherapy for Participants With Unresectable, Locally Advanced Stage III Non-Small Cell Lung Cancer (NSCLC) (KEYNOTE-799)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[170]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Recruitment Status: Completed
Medienart
1.693
Aufsätze
1.693
E-Artikel
1.693
E-Ressourcen
Zeitschriftentitel
1.693
ClinicalTrials.gov
Thema
1.693
610
Carcinoma, Non-Small-Cell Lung
Recruitment Status: Completed
1.388
Study Type: Interventional
1.258
Lung Neoplasms
596
Phase: Phase 2
305
Phase: Phase 1
296
Study Type: Observational
200
Phase: Phase 3
164
Medical Condition: Non-Small Cell Lung Cancer
160
Medical Condition: Non Small Cell Lung Cancer
142
Medical Condition: Non-small Cell Lung Cancer
134
Medical Condition: Carcinoma, Non-Small-Cell Lung
95
Carcinoma
81
Medical Condition: Lung Cancer
70
Phase: Phase 1/Phase 2
47
Phase: Phase 1, Phase 2
44
Medical Condition: Non-Squamous Non-Small Cell ...
38
Neoplasms
37
Melanoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
747
2020-
908
2010-2019
38
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.693
Englisch
Haven't found what you're looking for?
Wird geladen...